<DOC>
	<DOCNO>NCT02676596</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability , PK profile K-312 metabolites healthy Japanese non-Japanese adult .</brief_summary>
	<brief_title>Study Investigate Safety , Tolerability , Pharmacokinetics Pharmacodynamics K-312 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Subject provide write informed consent studyspecific evaluation perform . Subject healthy adult male female nonchildbearing potential age 18 45 year , inclusive . Subject body mass index 18.5 30 kg/m2 , inclusive . Subject hematology , coagulation , serum chemistry , urinalysis test result within reference range show clinically relevant deviation , judge Investigator . Subject presence active recur clinically significant cardiovascular , pulmonary , renal , endocrine , hepatic , neurologic , psychiatric , immunologic , hematologic , gastrointestinal , metabolic disease require medical treatment . Subject surgical medical condition might significantly alter absorption , distribution , metabolism , excretion K312 . Cholecystectomy permit postcholecystectomy gastrointestinal symptom . Subject clinically relevant abnormality clinical laboratory parameter .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>